Nobel Pharma, one of the leading pharmaceutical companies of Turkey, has been carrying on its operations since 1964. Its product range includes both the drugs developed and manufactured by other affiliate companies and those prescription or OTC products that are licensed by Nobel. Nobel also holds an esteemed place among pharmaceutical exporters in Turkey. With many representative offices established across Asia and Europe, Nobel has introduced its products into the global market. With thousands of employees across this wide geography, Nobel has one of the largest sales force with 1000 medical representatives and 95 district managers in Turkey, besides more than 400 medical representatives and 782 employees in overseas offices.
Adopting the vision of “being a worldwide, reliable organization with universal values’’ and the mission of “introducing state-of-the art and innovative products which promote the quality of life and make efficient use of available resources”, Nobel Pharma has been one of the fastest growing pharmaceutical companies during the last decade.
One of the main features that makes Nobel successful is the ability to renew its strategies rapidly whenever and wherever necessary with its flexibility and dynamism against the changing market conditions, which have been an essential feature in the dynamic Turkish market and in the developing Central Asia and Balkan countries.
Nobel’s activities are being supported by other subsidiaries of the same group, i.e. Ulkar Kimya (production of raw materials and micropellets), Nobel Pharma (manufacturing of finished products in all forms), and Fargem (R&D).
Nobel continues its search for global partners and new products on the one hand and it keeps on recruiting new countries to its list of operations on the other.